Phase II Study of S-1 in Combination With Radiotherapy in Esophageal Squamous Cell Carcinoma
Phase of Trial: Phase II
Latest Information Update: 20 Feb 2019
Price : $35 *
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary)
- Indications Oesophageal cancer; Squamous cell cancer
- Focus Adverse reactions; Therapeutic Use
- 14 Feb 2019 Status changed from active, no longer recruiting to completed.
- 06 Jan 2016 Planned End Date changed from 1 Mar 2018 to 1 Oct 2018 as reported by ClinicalTrials.gov record.
- 06 Jan 2016 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.